• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

科多尔省卵巢癌的基于人群研究:过去 20 年来的预后因素和相对生存率趋势。

Population-based study of ovarian cancer in Côte d'Or: prognostic factors and trends in relative survival rates over the last 20 years.

机构信息

Registre des Cancers du Sein et autres Cancers Gynécologiques de Côte d'Or, Centre Georges François Leclerc, Dijon, France.

出版信息

BMC Cancer. 2010 Nov 10;10:622. doi: 10.1186/1471-2407-10-622.

DOI:10.1186/1471-2407-10-622
PMID:21067600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2994825/
Abstract

BACKGROUND

The aim of this population-based study was to assess independent prognostic factors in ovarian cancer using relative survival (RS) and to investigate changes in RS rates from 1982 to 2005.

METHODS

Data on 748 patients with ovarian cancer were provided by the Côte d'Or gynaecologic cancer registry. The RS was estimated using a generalized linear model with a Poisson error structure. Relative survival and its 95% confidence interval (CI) were described at the following specific time points 1, 3 and 5 years. The effect of prognostic factors on survival was assessed with multivariate analyses of RS.

RESULTS

The median follow-up was 12 years. The RS rates at 1, 3 and 5 years were 81%, 55% and 44%, respectively. As compared with the period 1982-1989, an improvement in survival was found for the period 1998-2005: HR = 0.52[0.40-0.67]. Women who lived in urban areas had better RS: HR = 0.82[0.67-0.99]. Patients with epithelial types of ovarian cancer other than mucinous or endometrioid cancer had worse RS than those with serous histology. Age ≥ 70 years was associated with lower survival.

CONCLUSIONS

Period of diagnosis, stage at diagnosis, histology, place of residence and age were independent prognostic factors for survival in ovarian cancer. An improvement in the survival rate was observed after 1998 but a significant improvement was limited to advanced stage cancers.

摘要

背景

本基于人群的研究旨在使用相对生存率(RS)评估卵巢癌的独立预后因素,并探讨 1982 年至 2005 年 RS 率的变化。

方法

科多尔妇科癌症登记处提供了 748 例卵巢癌患者的数据。使用具有泊松误差结构的广义线性模型估计相对生存率。描述了以下特定时间点 1、3 和 5 年的相对生存率及其 95%置信区间(CI)。使用 RS 的多变量分析评估预后因素对生存的影响。

结果

中位随访时间为 12 年。RS 率在 1、3 和 5 年分别为 81%、55%和 44%。与 1982-1989 年相比,1998-2005 年的生存率有所提高:HR=0.52[0.40-0.67]。居住在城市地区的女性 RS 更好:HR=0.82[0.67-0.99]。与浆液组织学相比,卵巢癌上皮类型为黏液性或子宫内膜样癌以外的患者 RS 较差。年龄≥70 岁与生存率降低相关。

结论

诊断期、诊断时的分期、组织学、居住地和年龄是卵巢癌生存的独立预后因素。1998 年后生存率有所提高,但仅在晚期癌症中显著提高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d2/2994825/f2f1c44fdb75/1471-2407-10-622-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d2/2994825/f2f1c44fdb75/1471-2407-10-622-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d2/2994825/f2f1c44fdb75/1471-2407-10-622-1.jpg

相似文献

1
Population-based study of ovarian cancer in Côte d'Or: prognostic factors and trends in relative survival rates over the last 20 years.科多尔省卵巢癌的基于人群研究:过去 20 年来的预后因素和相对生存率趋势。
BMC Cancer. 2010 Nov 10;10:622. doi: 10.1186/1471-2407-10-622.
2
Population-based study of breast cancer in older women: prognostic factors of relative survival and predictors of treatment.基于人群的老年女性乳腺癌研究:相对生存的预后因素和治疗预测因素。
BMC Cancer. 2012 Oct 15;12:472. doi: 10.1186/1471-2407-12-472.
3
Non-Hodgkin's lymphoma: time trends for incidence and survival in Côte-d'Or, France.非霍奇金淋巴瘤:法国科多尔省的发病率和生存率的时间趋势
Int J Epidemiol. 1997 Oct;26(5):945-52. doi: 10.1093/ije/26.5.945.
4
Influence of stage at diagnosis on survival differences for rectal cancer in three European populations.诊断分期对三个欧洲人群中直肠癌生存差异的影响。
Br J Cancer. 1999 Oct;81(3):463-8. doi: 10.1038/sj.bjc.6690716.
5
Incidence and survival of epithelial ovarian, fallopian tube, peritoneal, and undesignated abdominal/pelvic cancers in Sweden 1960-2014: A population-based cohort study.1960-2014 年瑞典上皮性卵巢癌、输卵管癌、腹膜癌和未指定的腹部/盆腔癌的发病率和生存率:一项基于人群的队列研究。
BMC Cancer. 2021 Apr 26;21(1):465. doi: 10.1186/s12885-021-08169-w.
6
Breast cancer in men in Cote d'Or (France): epidemiological characteristics, treatments and prognostic factors.科多尔省(法国)男性乳腺癌:流行病学特征、治疗方法和预后因素。
Eur J Cancer Care (Engl). 2012 Nov;21(6):809-16. doi: 10.1111/j.1365-2354.2012.01365.x. Epub 2012 May 30.
7
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
8
Survival analysis of gynecological cancers in Southeast China, 2011-2020: A population-based study.2011-2020 年中国东南部妇科癌症的生存分析:基于人群的研究。
Cancer Epidemiol. 2024 Oct;92:102641. doi: 10.1016/j.canep.2024.102641. Epub 2024 Aug 20.
9
Population-based study of breast cancer survival in Cote d'Or (France): prognostic factors and relative survival.法国科多尔省乳腺癌生存情况的基于人群的研究:预后因素与相对生存率
Ann Oncol. 2008 Feb;19(2):276-83. doi: 10.1093/annonc/mdm491. Epub 2007 Oct 24.
10
Temporal trends in prehospital management of ST-segment elevation myocardial infarction from 2002 to 2010 in Cote d'Or: data from the RICO registry (obseRvatoire des Infarctus de Cote d'Or).2002 年至 2010 年科多尔省 ST 段抬高型心肌梗死的院前管理时间趋势: RICO 登记处(科多尔省心肌梗死观察站)的数据。
Arch Cardiovasc Dis. 2012 Dec;105(12):649-55. doi: 10.1016/j.acvd.2012.08.004. Epub 2012 Nov 9.

引用本文的文献

1
Rural-metropolitan disparities in ovarian cancer survival: a statewide population-based study.农村-城市间卵巢癌生存差异:全州范围基于人群的研究。
Ann Epidemiol. 2018 Jun;28(6):377-384. doi: 10.1016/j.annepidem.2018.03.019. Epub 2018 Apr 12.

本文引用的文献

1
Reasons for improved survival from ovarian cancer in New South Wales, Australia, between 1980 and 2003: implications for cancer control.
Int J Gynecol Cancer. 2009 May;19(4):591-9. doi: 10.1111/IGC.0b013e3181a3a436.
2
Epithelial ovarian cancer in Greece: a retrospective study of 1,791 patients by the Hellenic Cooperative Oncology Group (HeCOG).希腊上皮性卵巢癌:希腊合作肿瘤学组(HeCOG)对1791例患者的回顾性研究。
Anticancer Res. 2009 Feb;29(2):745-51.
3
A population-based 5-year cohort study including all cases of epithelial ovarian cancer in western Sweden: 10-year survival and prognostic factors.一项基于人群的5年队列研究,涵盖瑞典西部所有上皮性卵巢癌病例:10年生存率及预后因素。
Int J Gynecol Cancer. 2009 Jan;19(1):116-23. doi: 10.1111/IGC.0b013e3181991b13.
4
Improvement of survival in sex cord stromal tumors - an observational study with more than 25 years follow-up.性索间质肿瘤患者生存率的改善——一项超过25年随访的观察性研究
Acta Obstet Gynecol Scand. 2009;88(4):440-8. doi: 10.1080/00016340902741208.
5
Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: a population-based cohort study of all patients in western Sweden with long-term follow-up.辅助性紫杉醇和顺铂对晚期上皮性卵巢癌的疗效:一项基于瑞典西部所有患者的队列研究及长期随访
Acta Obstet Gynecol Scand. 2008;87(12):1343-52. doi: 10.1080/00016340802495491.
6
Outcome of ovarian cancer patients who underwent incomplete surgical staging.接受不完全手术分期的卵巢癌患者的预后
J Med Assoc Thai. 2008 Sep;91(9):1323-30.
7
Cancer incidence and mortality in France over the period 1980-2005.1980年至2005年期间法国的癌症发病率和死亡率。
Rev Epidemiol Sante Publique. 2008 Jun;56(3):159-175. doi: 10.1016/j.respe.2008.03.117. Epub 2008 Jun 10.
8
Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.与其他上皮细胞类型相比,透明细胞卵巢癌的预后是否更差?一项对1411例透明细胞卵巢癌的研究。
Gynecol Oncol. 2008 Jun;109(3):370-6. doi: 10.1016/j.ygyno.2008.02.006. Epub 2008 Apr 18.
9
Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study.Ⅲ期上皮性卵巢癌的预后因素:一项妇科肿瘤学组研究
J Clin Oncol. 2007 Aug 20;25(24):3621-7. doi: 10.1200/JCO.2006.10.2517.
10
Trends in population-based cancer survival in Germany: to what extent does progress reach older patients?德国基于人群的癌症生存率趋势:进展在多大程度上惠及老年患者?
Ann Oncol. 2007 Jul;18(7):1253-9. doi: 10.1093/annonc/mdm126. Epub 2007 Apr 29.